HMPV Surge in US: Cases Rise, Prompting Health Alerts & Prevention Tips
The circulation of a respiratory virus, human metapneumovirus (HMPV), is prompting increased medical consultations in several states across the United States, particularly in California and New Jersey. Health authorities are observing sustained increases in laboratory-confirmed cases and detection in wastewater surveillance, and whereas not new, the virus is gaining attention due to the lack of a specific vaccine or antiviral treatment. This comes as communities continue to navigate the presence of other common respiratory illnesses like RSV, influenza, and COVID-19.
HMPV’s Increasing Presence in the US
According to reports from the Centers for Disease Control and Prevention (CDC), HMPV cases have coincided with increased demand on emergency services. The national surveillance system, NREVSS, indicated that by late February, HMPV accounted for just over 5% of weekly positive respiratory tests – a rise from the previous month and approaching levels seen last year. The California Department of Public Health is also tracking the increase. This uptick is particularly noticeable in communities like Merced in California’s Central Valley, and Novato and Sunnyvale in the San Francisco Bay Area, where wastewater monitoring through the WastewaterScan Dashboard has revealed notable increases in HMPV levels.
In New Jersey, the state’s Department of Health attributes the rise in medical visits to the concurrent circulation of HMPV, RSV, influenza, and COVID-19. The situation is placing additional strain on healthcare facilities as they manage multiple respiratory illnesses simultaneously.
Understanding Human Metapneumovirus
First identified in 2001, HMPV belongs to the Pneumoviridae family, the same family as RSV. It causes infections of both the upper and lower respiratory tracts. Common symptoms include cough, nasal congestion, fever, and difficulty breathing. More severe cases can lead to bronchitis or pneumonia, particularly in vulnerable populations. The virus typically circulates during the winter and spring months, with an incubation period of three to six days.
Those most at risk from severe illness include infants and young children, adults aged 65 and older, and individuals with chronic health conditions. Because there is no vaccine or specific antiviral treatment available, managing HMPV infections focuses on supportive care – relieving symptoms and preventing complications.
Current Treatment and Prevention Strategies
Currently, medical care for HMPV focuses on symptom management and supportive care. For those experiencing difficulty breathing, supplemental oxygen may be required. The CDC emphasizes the importance of staying hydrated and avoiding close contact with others while sick. Cleveland Clinic also highlights this approach. It’s crucial to avoid self-treating and to consult a healthcare professional for persistent or severe symptoms.
Preventing the spread of HMPV relies on standard hygiene practices:
- Frequent and thorough handwashing
- Avoiding touching the eyes, nose, and mouth with unwashed hands
- Reducing close contact with individuals exhibiting respiratory symptoms
- Regular cleaning and disinfection of frequently touched surfaces
- Improving ventilation in indoor spaces
- Covering the mouth and nose when coughing or sneezing
The virus spreads through direct contact with respiratory secretions and contaminated surfaces. Specific isolation measures beyond those recommended for other respiratory viruses are not currently in place.
Wastewater Surveillance: An Early Warning System
The apply of wastewater surveillance is proving to be a valuable tool in tracking the spread of HMPV and other respiratory viruses. By monitoring viral levels in wastewater, public health officials can gain an early indication of increasing transmission within a community. This allows for proactive preparation of healthcare systems and targeted public health messaging. The WastewaterScan Dashboard, for example, provides data on HMPV concentrations in wastewater across various locations.
Looking Ahead: Ongoing Monitoring and Research
The CDC and state health departments are continuing to monitor HMPV circulation and provide updates to the public. The NREVSS data is updated weekly, offering a current snapshot of the virus’s activity. While the current increase is concerning, authorities emphasize that the risk to the general population remains low. However, continued vigilance and adherence to preventative measures are essential, particularly for those at higher risk of severe illness.
The CDC is also actively involved in ongoing research to better understand HMPV, including its transmission patterns, the severity of illness it causes, and potential strategies for prevention and treatment. Further studies are needed to explore the possibility of vaccine development and identify effective antiviral therapies. For now, the focus remains on mitigating the spread through established public health practices and providing supportive care to those who turn into infected.
As with other respiratory viruses, staying informed through official public health updates and consulting with a qualified healthcare professional are the most important steps individuals can take to protect themselves and their communities.